ATF4 and hepatocellular carcinoma: Thus, we treated HCC cells with the proteasome inhibitor MG132 and we found that it efficiently blocked the downregulation of ATF4 induced by the siRNA‐mediated depletion of YAP/TAZ (Appendix Fig S7A).